TrianglePUBLICATIONS · 16034041
Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2005 Jul 20
- First author
- von der Maase H
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- von der Maase H
- type
- Author
- name
- Sengelov L
- type
- Author
- name
- Roberts JT
- type
- Author
- name
- Ricci S
- type
- Author
- name
- Dogliotti L
- type
- Author
- name
- Oliver T
- type
- Author
- name
- Moore MJ
- type
- Author
- name
- Zimmermann A
- type
- Author
- name
- Arning M
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- von der Maase H
- type
- Author
- name
- Sengelov L
- type
- Author
- name
- Roberts JT
- type
- Author
- name
- Ricci S
- type
- Author
- name
- Dogliotti L
- type
- Author
- name
- Oliver T
- type
- Author
- name
- Moore MJ
- type
- Author
- name
- Zimmermann A
- type
- Author
- name
- Arning M
- type
- Author
- bibliography ids
- nci-bib-7745855a821537e7e08d9648
- book metadata
- content sha256
- f718cc7fe572c43c081b0fb4860858fddff44d4e5858ba8841bf1e4ad7f81c1c
- document type
- citation
- dois
- 10.1200/JCO.2005.07.757
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:16034041
- immutable id
- pubmed:16034041@f718cc7fe572c43c081b0fb4860858fddff44d4e5858ba8841bf1e4ad7f81c1c
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- Source null
- issn print
- 0732-183X
- issue
- 21
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 4602-8
- volume
- 23
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 16034041
- provenance
- batch id
- acd1a19ec1fd03e5b423
- provider
- NCBI PubMed ESummary
- record sha256
- 04aabc780c4650442aaee3d482de6123a23e342397bb49e0480247317aa8b9f8
- response sha256
- 06f2789b1faf1384eea463ec33b6ace6458084d0e39588df6f3b23cecac27647
- retrieved at
- 2026-09-09T23:46:01.895425+00:00
- publication date
- display
- 2005 Jul 20
- precision
- day
- year
- 2005
- publication types
- Clinical Trial
- Clinical Trial, Phase III
- Comparative Study
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer.
Preserved source evidence · Not medical advice